A New Role for Hemoglobin A1c Should It Be Used to Screen for Diabetes?By Gina Rollins
As the prevalence of pre-diabetes and diabetes rises, the desire is great to find ways to identify at-risk patients earlier in their disease process. Now, an independent panel has proposed using HbA1c as both a screening and diagnostic tool.
Proprietary Lab-Developed Tests Responding to Innovation or Skirting Regulation?By Bill Malone
Lab-developed tests allow companies a way to get novel tests onto the market as quickly as possible. However, FDA and other stakeholders remain cautious as more and more of these tests come online through the so-called “back door” into clinical practice.
Endocrine Testing Improving Patient Care with Tandem Mass Spectrometry By Ravinder Jit Singh, PhD
Although labs routinely use automated immunoassays for steroids, proteins, and peptides, FDA-cleared immunoassays are not available for all endocrine analytes that labs need to measure. LC-MS/MS can help labs fill the gap and can offer improved precision and accuracy over other methods.
NCQA Report: Reform Must Tackle Uneven Care
LabCorp Cuts OvaSure Test
News from the FDA
Download the entire issue
New Trends in Lab Accreditation
C. difficile Diagnostic Challenges